Treatment OutcomePrevalenceOutcome Assessment (Health Care)Retrospective StudiesRisk FactorsFollow-Up StudiesPregnancy OutcomeProspective StudiesCross-Sectional StudiesPrognosisCohort StudiesTime FactorsAntitubercular AgentsAge FactorsSeverity of Illness IndexLogistic ModelsUnited StatesDirectly Observed TherapyHIV InfectionsOutcome and Process Assessment (Health Care)Sex FactorsCognitive TherapyPredictive Value of TestsPregnancyInfant, NewbornTreatment FailureSurvival AnalysisAge DistributionRecurrenceSurvival RateMultivariate AnalysisTuberculosis, PulmonaryCombined Modality TherapyQuestionnairesIncidencePatient ComplianceSubstance-Related DisordersIndiaSex DistributionRisk AssessmentBrazilSocioeconomic FactorsTuberculosis, Multidrug-ResistantExtensively Drug-Resistant TuberculosisChi-Square DistributionGenotypeRandomized Controlled Trials as TopicQuality of LifeOdds RatioAlcoholismOpioid-Related DisordersRegression AnalysisTuberculosisLongitudinal StudiesKaplan-Meier EstimateComorbidityHealth SurveysBuprenorphineSmokingRural PopulationSubstance Abuse Treatment CentersPsychiatric Status Rating ScalesChronic DiseasePsychotherapyDrug Therapy, CombinationChinaCoinfectionUrban PopulationNeoplasm StagingPopulation SurveillanceReproducibility of ResultsHospitals, Chronic DiseaseTemperancePatient SatisfactionCase-Control StudiesSouth AfricaDemographyAntineoplastic Combined Chemotherapy ProtocolsAnti-Bacterial AgentsMental DisordersRegistriesAnalysis of VarianceDepressive Disorder, MajorSensitivity and SpecificityEpidemiologic MethodsPostoperative ComplicationsDepressionJapanCocaine-Related DisordersDisease ProgressionGreat BritainMethadoneRemission InductionStatistics, NonparametricObesityAnti-HIV AgentsProportional Hazards ModelsPatient DropoutsBody Mass IndexUganda